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Physicists have and continue to play a major role in the creation and introduction of novel tech-
nology into medical care. This review covers some of the highlights of contributions of medical
physicists to the field of radiation oncology during the history of the AAPM. While not compre-
hensive, the broad scope of developments and their impact hints at the importance of the medical
physicist in advancing the field in the past, present, and future. © 2008 American Association of
Physicists in Medicine. DOI: 10.1118/1.3021006Key words: innovation, medical physics, history, radiation oncologyI. INTRODUCTION
One of the most important roles that medical physicists have
played is the development and introduction of new and use-
ful technologies into clinical medicine. Some of these tech-
nologies were invented and implemented within the medical
physics community e.g., linear accelerators, digital subtrac-
tion angiography, radiation therapy treatment planning. Oth-
ers were outside technologies that were put to work in the
clinical environment e.g., radionuclides. Still others were
developed for medical use outside the hospital and applied
clinically with medical physics help e.g., image intensifiers,
gamma cameras. These devices unquestionably improved
the diagnosis and treatment of patients during the 50 year
AAPM era.
This article reviews a very limited selection of such tech-
nologies, with a specific focus on the field of radiation on-
cology. Reviews are never complete. The random walk pre-
sented below is largely colored by the experiences of the
authors. Indulgence is requested from the multitude of medi-
cal physicists whose contributions equaled or exceeded the
few discussed here.
Three benchmark years are 1958, the founding of AAPM,
1983, the 25th anniversary, and 2008, the 50th anniversary.
To provide some focus, a hypothetical patient with pancre-
atic cancer and/or possible multiorgan metastasis is pictured
at each benchmark.
II. 1958: AAPM FOUNDED
In 1958, the pancreas was essentially invisible to all of the
available imaging modes. These were radiography using film
or film-screen systems, GI fluoroscopy using direct fluores-
cent screens and barium, and nuclear detectors observing in-
organic radionuclide compounds. Brain and liver metastasis
were almost invisible. Lung metastases could be seen once
they grew to a size of several centimeters. Definitive diag-
noses were made using exploratory surgery. Treatment op-
tions for the pancreas were usually a choice of radon seeds or
5641 Med. Phys. 35 „12…, December 2008 0094-2405/2008/35„250 kVp external beam therapy. A few centers offered mega-
voltage beams. External beam treatment planning was done
by hand using water isodose curves and educated guesses
regarding the locations of the tumor and nearby critical or-
gans. Brachytherapy for a pancreatic cancer could not be
planned. Post-implant radiographs were used to estimate the
implanted dose. These calculations were generally based on
the major diameters of the implant, the implanted activity,
and an estimate of the homogeneity of the implant.
II.A. Treatment delivery
In 1958, there were few early cancers that could be iden-
tified using available imaging technologies. Exploratory sur-
gery was the available alternative for the diagnosis and stag-
ing of disease. Radiation therapy was typically used to treat
the inoperable cancers found by this process. Most “deep”
external beam therapy was delivered using 250 kVp beams
Fig. 1 because there were only a few megavoltage ma-
chines available in the USA. Most of these were 1–2 MV
x-ray sources. A few betatrons were available, producing
both photons and electrons. Radon seed permanent implants
were placed in deep seated lesions at the time of surgery.
Removable implants using radium needles and capsules were
applied in accessible locations Fig. 2.
The first medical linear accelerator in the United States
was put into use at Stanford University about the same time
as the AAPM was founded. This system, a 6 MV accelerator,
was developed by the physics group under the vision of
Henry Kaplan, M.D. in Collaboration with EL Ginzton, and
began treatments in 1956 Fig. 3. Dr. Ginzton was a pioneer
in the design of linear accelerators for national laboratories,
as well as medical purposes, and was a cofounder of Varian
Associates. The first clinical physicist working with the Stan-
ford Medical Accelerator, Mitchell Weissbluth, described the
1
characteristics of the system in one of a series of reports on
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5642 S. Balter and J. M. Balter: Novel technologies in radiation oncology 5642the device,2–4 and further studied biological properties of
higher energy photons available on the Stanford Linear
Accelerator.5
Particle therapy was initially proposed in 1946.6 The first
treatments at various high energy particle physics accelera-
FIG. 1. 250 kVp at MSKCC. This photo was taken in the late 1930s. The
machines in service in the late 1950s were quite similar in appearance.
FIG. 2. Radium needle implant to the tongue. Patterson–Parker dose calcu-
lations accounted for only one end of the implant being crossed. Note the
magnification ring.
Medical Physics, Vol. 35, No. 12, December 2008tors in the 1950s were followed by more dedicated treat-
ments at the Harvard Cyclotron Laboratory. In this early pe-
riod of particle therapy, various more exotic heavy and
subatomic particles, such as neutrons,7,8 pi mesons,9 and
heavier ions10–12 were discussed and experimented with. The
period from 1958–83 was a very active era in particle
therapy research, with a wide variety of experiments report-
FIG. 3. The first medical linear accelerator at Stanford University courtesy
of R. Hoppe.
FIG. 4. MSKCC Betatron electrons only and phantom with
inhomogenieties.
5643 S. Balter and J. M. Balter: Novel technologies in radiation oncology 5643ing on energy deposition and biological effects. Clinical neu-
tron accelerators were developed, including systems located
within hospitals.
II.B. Calibration and dosimetry
Determining “dose” in radiotherapy was a major research
focus of the medical physics community in the 1950s. Areas
of concern were determining the activity of a radioactive
source, the output of a supervoltage machine, and the distri-
bution of dose within a patient.
The “New York Millicurie” was established by intercom-
parison of standards between institutions in the region. These
interactions between medical physicists contributed to the
formation of RAMPS a decade before AAPM. The definition
of the activity of a sample was eventually stabilized by the
National Bureau of Standards now NIST.
Because of electron equilibrium issues, the calibration of
high-energy machines was limited by the physics of the free-
air chamber to photon energies below 3 MeV. Various tech-
niques, including absolute calorimetric measurements and
cavity ionization methods, were developed locally to enable
calibration at emerging higher energies. Major centers had
their favorite high precision methods. Unfortunately, the dis-
agreement between centers often exceeded the claimed pre-
cisions. The Scientific Committee on Radiation Dosimetry
SCRAD was formed to resolve these differences. The 1966
and 1971 SCRAD reports on electron and photon
dosimetry13,14 were fundamental to dosimetric traceability
FIG. 5. Lansverk electrostatic dose meter with “miniature” ion chambers. Th
were small enough to place in a phantom. Images from ORNL courtesy ofand the intercomparison of clinical results.
Medical Physics, Vol. 35, No. 12, December 2008Direct measurements of patient dose were essentially im-
possible in the 1950s. Phantom measurements were tedious
and only yielded results under highly defined conditions.
Figure 4 illustrates such an experiment using an “advanced”
anthromorphic phantom with cork lungs. A few miniature ion
chambers Fig. 5 could be charged, placed within cavities in
the phantom, irradiated, and visually read using an electro-
scope. These measurements were usually used to normalize
the dosimetry of films placed between phantom slices. Pre-
cision film dosimetry was itself an art. Cameron’s introduc-
tion of TLD into radiation dosimetry changed the
paradigm.15 As many TLD powder capsules later chips as
the experimenter had patience to prepare could be put into a
phantom and read out at leisure. Of greater importance, TLD
could be used for surface or intracavitrary dosimetry during
routine examinations or treatments.
II.C. Treatment planning „1958–1983…
The era started with manual treatment planning for exter-
nal beam therapy being done with central axis depth dose
tables such as those found in Johns and Cunningham.16 Two
dimensional isodose curves were available and used to pre-
pare 2D treatment plans Fig. 6. Close inspection of the
esophageal treatment plan Fig. 7 shows typical simplifica-
tions used in this era: The isodose distribution is shown with-
out correction for skin curvature and the beams are not per-
turbed by the spine shown or lungs not shown.
It was always understood that the patient was neither a
homogeneous ellipsoid nor a rectangular box. Procedures
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5644 S. Balter and J. M. Balter: Novel technologies in radiation oncology 5644Eycleshymer and Schoemaker’s 1911 cross-sectional atlas
was used to estimate the location of internal structures. This
atlas was based on the average anatomy of 11 subjects. It
was last reprinted in 1970.17 A typical section is shown in
Fig. 9. Such drawings were occasionally optically warped to
fit the measured contour.
In the 1960s, there was a commercially available tomog-
raphy which could image a patient in a supine position Fig.
10. Diagnostic imaging underwent revolutionary changes in
the 1970s. These included the early development of CT,
MRI, and PET imaging. The advent of CT in the early 1970s
and MRI at the end of this decade provided previously un-
available means for noninvasive delineation of the patient’s
anatomy and extent of disease. PET was emerging, but was
not used in large clinical volumes at this time.
As soon as CT was available, it had an immediate and
major impact on treatment planning. For example, Emami et
al. found chest CT to be essential in 17 of 32 patients. Simi-
lar results were found by many other groups.18 The basic
improvements brought by CT were better delineation of tar-
get and normal structures, and estimation of tissue density.
Figure 11 illustrates an early CT-based plan including tissue
density corrections. Although the plan is crude by 2008 stan-
dards, it reflects a significant advance over prior dose esti-
mation methods e.g., in Fig. 7.
Computer based treatment planning was proposed in the
1950s by Tsien.19 The increasing availability of digital com-
puters provided Stovall and Shalek at Anderson20 and Balter
and Laughlin at Memorial21 means to develop brachytherapy
dosimetry programs in the early sixties. External beam pro-
grams soon followed.22 By today’s standards, this first gen-
eration of clinical programs were unbelievably slow. The
first clinical Memorial brachytherapy program required
100 ms for a single inverse square calculation. Its output was
usually presented as points with 1 cm spacing; the isodose
curves were drawn by hand Fig. 12. Within a few years,
FIG. 6. Isodose curves from typical systems in use in the mid 1960s Johns
and Cunningham.speeds had increased to the point where computational spac-
Medical Physics, Vol. 35, No. 12, December 2008ing could be reduced to the size of a single teletype character
or to adequately drive a plotter Fig. 13.
Treatment planning offices in Memorial were overfilled
by local physicists who dropped by to run plans for their
patients. A remote treatment planning network was devel-
oped to give these individuals access at their own
institutions.23 This program ran for several years until semi-
commercial treatment planning machines such as the pro-
grammed console24 and the fully commercial SHM RAD-8
Ref. 25 became inexpensive enough to be affordable by
most radiotherapy centers. These devices are shown in Figs.
14 and 15.
FIG. 7. Manual cobalt treatment plan from the mid 1960s. Note isodose
curves in air, sparse anatomy, and the absence of density corrections Johns
and Cunningham.FIG. 8. Mechanical contouring device c 1965 MSKCC.
5645 S. Balter and J. M. Balter: Novel technologies in radiation oncology 5645The RAD-8 image Fig. 15 was extracted from an adver-
tisement in Radiology published in the early 1970s. The ad
states that the system “gives you the added computational
power of a 16 k minicomputer, the PDP-8.” The same ad
also states that there were 20 000 PDP-8 computers installed
worldwide.
CT descriptions of patients and treatment planning com-
puters came together in the late seventies. Internal and exter-
nal contours were initially input by tracing the photographic
output of the CT scanner. The one advantage of this tedious
method of data input is that it could work with any CT scan-
ner and any treatment planning computer. Digital versions of
CT images were available on 9-track magnetic tape and/or
8-in. floppy disks. Every CT manufacturer had their own
proprietary data format. The need for a common format was
recognized by the AAPM. Report 10 Ref. 26 specifies a
common interchange format. The basic internal structure of
this format was tag-value pairs. This flexible format was
FIG. 9. Page from anatomical cross section atlas often used for pre-CT
treatment planning Eycleshymer and Schoemaker.
FIG. 10. Mechanical axial tomography Toshiba designed for treatment
planning. Patient is in the treatment position. Note the film cassette holder.
Medical Physics, Vol. 35, No. 12, December 2008adopted by ACR-NEMA for digital data storage and eventu-
ally evolved into a key part of DICOM.
There was and is a real need to verify the adequacy of
the treatment plan. Portal films, taken on the treatment ma-
chine itself, had been employed for a long time. These im-
ages are adequate when the plan consists of a few static
fields. The process was increasingly inefficient as the number
of fields increased and almost unusable for moving fields.
Physical radiation therapy simulators were introduced in the
late 1960s.27–30 These simulators replicated the geometry and
mechanical movements of the treatment machine with the
FIG. 11. Betatron treatment plan c 1980. CT cross-sectional image of
anatomy. Plan is corrected for tissue density courtesy of J. Cunningham.
FIG. 12. One plane of the output of a seed implant calculation. The isodose
curves were drawn manually. The implanted volume was defined by calcu-
lating the intersection lines between each seed and every other seed. The
high-dose region outside the implant was due to close seeds in a different
plane MSKCC.
5646 S. Balter and J. M. Balter: Novel technologies in radiation oncology 5646improved imaging associated with a diagnostic fluoroscope
kV beam and image intensifier Fig. 16.
Brachytherapy planning requires knowledge of the source
positions. The mathematics of reconstructing the location of
a metallic object in a patient were well described in the first
volumes of most of the major radiological journals. The ma-
jor problems needed to extend the mathematics to the auto-
matic description of seed implants are the identification of
the same seed on each of the radiographs used for the recon-
struction and information on the location of the x-ray tube
focal spot relative to each image. A rigid frame provided the
solution Fig. 17. Fixed tube positions and fiducials in the
cassette trays define the geometry, and thus lines can be
traced from each seed image back to the focal spot. The
intersections or closest approaches within a specified toler-
ance of the lines from two or three films uniquely identify
individual sources.31 This method seems to be independently
FIG. 13. Output for a three field treatment plan sent by teletype from the
Memorial Dose Distribution Computation Service. The beam information
and wedges were hand drawn later. The percentage depth dose was calcu-
lated for each character position. The character coded its value Holt.
FIG. 14. Programmed Console c 1967 software and data resided on the
magnetic striped cards. Note the graphic input device used for entering
contours Cunningham.
Medical Physics, Vol. 35, No. 12, December 2008reinvented every decade for one treatment purpose or
another.32 A variant is currently used for HDR reconstruc-
tions. Here, two sets of fiducial markers are used to construct
the location of the focal spot relative to the film. Individual
source positions are unambiguously identified by the shapes
of targets on continuous dummy ribbons.
II.D. Multileaf collimation
The need to spare normal tissues has been apparent from
an early stage of radiotherapy. While beam quality is one
factor in tissue sparing, field shaping can arguably be con-
sidered most critical to this process. Various forms of field
shaping devices have been developed over the past 5 de-
cades, but the multileaf collimator MLC is clearly an in-
vention that has proven critical to the advancement of precise
radiation delivery.
Takahashi described the MLC in 1965 as part of a system
to aid in rotational therapy.33 In 1979, Sofia reported on a
computer-controlled MLC, paving the way for modern MLC
design and implementation.34
III. 1983: AAPM SILVER ANNIVERSARY
The AAPM’s first quarter century was a golden era for
medical physics and the radiological sciences. The funda-
FIG. 15. Rad-8 treatment planning system c 1973 from Radiology, re-
printed with permission.
FIG. 16. Radiation therapy simulator for an 80 cm cobalt machine c 1970.
Note that the results were documented by placing a cassette in front of the
image intensifier MSKCC.
5647 S. Balter and J. M. Balter: Novel technologies in radiation oncology 5647mental discoveries of this era laid the groundwork for dra-
matic advances in the precision of treatment planning, de-
liver, and verification that have been realized in the past
quarter century. As the 1980s unfolded, the pancreas and
metastatic foci could generally be seen using a combination
of CT, MRI, and PET imaging. Radiotherapy was generally
delivered using megavoltage photon and electron beams.
Treatments were planned with the aid of CT-determined
anatomy of individual patients, but not in general fully uti-
lizing the three-dimensional data for planning and dose cal-
culation. Treatment delivery was verified using portal films.
CT brought with it the virtual elimination of exploratory sur-
gery, and as a consequence ad hoc seed brachytherapy
sharply declined. The treatment of a pancreatic cancer pa-
tient was in general very simple and low dose, due to toxicity
risk.
III.A. Treatment planning „1983–2008…
The improvements in power of computers available for
treatment planning helped spur investigations into more so-
phisticated dose calculation algorithms. A significant number
of innovations in three-dimensional dose calculation oc-
curred in the last 25 years. Included in these are improve-
ments in empirical models of dose deposition,35 and the ad-
vent of Monte Carlo methods for modeling radiation
transport in medical linear accelerators.36,37 The introduction
of convolution methods for dose modeling has led to wide-
spread improvements in dose modeling accuracy for com-
mercially available treatment planning systems.38–41
In relation to improved calculation methods, visualization
tools have also dramatically improved our ability to plan
treatments conformally. The beam’s eye view concept42 was
a critical step in understanding the relationship between
beam orientation, field shaping, and normal organ sparing
Fig. 18.
A critical element for improving our understanding of
anatomy and ability to optimize plans is the development of
FIG. 17. Apparatus for the automatic localization of implanted seeds c 1970
MSKCC.the patient model from multiple sources of information.
Medical Physics, Vol. 35, No. 12, December 2008Three-dimensional image alignment techniques have been
pioneered by medical physicists, notably with the introduc-
tion of surface fitting for aligning MRI, CT, and PET images
of the brain,43 and continuing through a series of innovations
over subsequent years.
III.B. CT simulation
The advances in three-dimensional treatment planning
mentioned above provided a true paradigm shift in radiation
oncology. The intrinsic volumetric representation of the pa-
tient moved from the imagination of the physician and a few
related measurements to a more palpable three-dimensional
model of the patient from which more direct visualizations of
the influence of treatment geometry could be appreciated.
This digital patient model could be extended to more elo-
quent applications and could even serve as the reference
model for the patient as a basis for setup verification. The
generation of the digitally reconstructed radiograph44 al-
lowed for treatment geometry to be viewed as if an x-ray
image was acquired through the patient along the beam path.
This tool, combined with advanced three-dimensional visu-
alization methods, allowed for the evolution of virtual, or
CT-based, simulation.45,46 The ability to replace the conven-
FIG. 18. Early beam’s eye view projection courtesy of D. McShan.tional simulator with a patient model derived from CT scans
5648 S. Balter and J. M. Balter: Novel technologies in radiation oncology 5648has been one of the most dramatic advances in radiotherapy,
both reducing the complexity of simulation, and expanding
the routine use of complex beam geometries for more ad-
vanced sparing of normal tissues and target coverage. Figure
19 shows an early picture from the virtual simulation system
invented by Sherouse and colleagues at the University of
North Carolina.
The second half of the modern history of the AAPM saw
the growth of dedicated clinical particle therapy centers. The
first clinical center in the United States was established at
Loma Linda University Medical Center in 1990. The North-
east Proton Center opened in 2002, shifting the clinical op-
eration from the Harvard Cyclotron laboratory. While phys-
ics research facilities still continue to treat some patients
with their beam lines, additional dedicated medical proton
facilities opened in Texas and Florida, and a number of ad-
ditional private centers are in various phases of planning and
construction in the United States.
III.C. Intensity modulated radiation therapy
From early on, it was understood that the precise delivery
of radiation involves consideration of a very large number of
parameters modality, energy dose rate, orientation, field
shape, and in fact early papers point to the considerations of
“optimal” methods of configuring radiation treatments.47,48
The introduction of computer-controlled, dynamic field shap-
ing, however, was one of two key components that led to the
development of intensity modulated radiotherapy IMRT.
A critical development in the generation of IMRT was the
suggestion by Brahme that alteration of the radiation fluence
pattern as a beam rotates around the patient can spare central
critical structures.49 Brahme further went on to speculate that
dynamic field shaping devices could potentially deliver the
complex fluence patterns needed to achieve organ sparing
and target dose coverage.50,51 Subsequent innovations in
FIG. 19. Screen capture from an early use of a virtual simulator at the
University of North Carolina courtesy of G. Sherouse.treatment plan optimization looked at reconstruction
Medical Physics, Vol. 35, No. 12, December 2008algorithms,52 linear programming methods,53 and eventually
iterative optimization methods, which are still being actively
improved.
While these concepts presented a very exciting paradigm,
the planning and delivery of such treatments was still pend-
ing. Carol, a neurosurgeon, conceived and developed the first
practical method of delivering non-uniform fluence patterns
during gantry rotation. His company, NOMOS, introduced a
binary MLC system which, in combination with linear accel-
erators operating in arc mode, became the first commercial
IMRT device.54
The invention of helical CT by Kalender in 1989 Ref. 55
provided another breakthrough in imaging as well as IMRT
Fig. 20. In addition to paving the way for slip-ring scanners
with dramatic improvements in speed, this method of trans-
porting radiation to a patient paved the way for helical tomo-
therapy, as envisioned and developed by Mackie and
colleagues56,57 Fig. 21.
III.D. Image guided radiotherapy
The use of portal films demonstrated the importance of
anatomically based treatment verification. Early film-based
verifications took significant time and resources, and typi-
cally required a great deal of skill and time for visual inter-
pretation of field shapes and sizes, as well as their relation-
ship to skeletal anatomy visible in these fairly low contrast
megavoltage projection radiographs. The advent of elec-
tronic portal imaging58–62 played a key role in advancing this
paradigm, and showed the wide array of clever approaches to
a technological problem advanced primarily by medical
physicists. Digital portal images, while initially of fairly poor
quality, were immediately amenable to digital manipulation,
including filtering to improve visual interpretation of
information,63–66 manual and automated field shape
verification,67–72 and most importantly image and feature
alignment to validate patient positioning.73–78 Such advances
are at the core of the modern era of image guided radiation
therapy.
A major technological breakthrough in digital imaging
FIG. 20. The helical “spiral” scanning CT process described in 1989 cour-
tesy of W. Kalender.had significant influence from the needs of improved portal
5649 S. Balter and J. M. Balter: Novel technologies in radiation oncology 5649imaging. Antonuk and Street, working with the emerging
technology of hydrogenated amorphous silicon arrays, intro-
duced active matrix flat panel imagers to radiography. Such
technology has revolutionized digital radiography,79 and has
become a staple for setup verification in radiation oncology.
Figure 22 shows a prototype imager and early radiograph.
Early measurements of precision of treatment clearly
demonstrated the importance of verification as a critical ele-
ment in effective radiotherapy. Early in-room megavoltage
CT technology was developed at the same time as portal
imaging.80 In the 1990s, two concepts of in-room diagnostic
CT imaging emerged. While some groups experimented with
placing CT scanners in the treatment room, others, most no-
tably Jaffray and colleagues at William Beaumont Hospital,
applied cone beam reconstruction methods to the area detec-
tors used for portal and prototype gantry-mounted diagnos-
tic imaging, thus introducing kilovoltage cone beam
CT.81–84 This technology is now spreading very rapidly
through the radiotherapy community, providing significant
detailed information of the patient at treatment that we are
still learning how to optimally utilize.
III.E. “4D” radiotherapy—Managing motion
The same factors that motivated improvements in local-
ization methods for precision therapy led to initial studies of
organ movement, perhaps one of the most active areas of
FIG. 21. Benchtop tomotherapy prototype system incorporating a NOMOS
collimator courtesy of T. Mackie.
(a) (b)
FIG. 22. Photo of an early prototype, active matrix flat-panel imager em-
ploying a 6440 pixel, indirect detection array with a 900 m pixel pitch.
b Image from this prototype, obtained on October 24, 1990 at 100 kVp and
1.1 mA, of a “Scottish Thistle” tie pin, representing the national flower of
Scotland. Courtesy of Larry Antonuk, Dept. of Radiation Oncology, Univer-
sity of Michigan.
Medical Physics, Vol. 35, No. 12, December 2008research and development in the field of radiotherapy today.
One of the earliest studies of organ movement was the dem-
onstration of prostate movement under differential bladder
and rectal filling85 Fig. 23. Studies such as this were
heavily influenced by medical physicists, who developed im-
age analysis tools, models of organ movement, and
interventions86 to minimize the impact of physiological
movement on treatment accuracy.
Investigations led by medical physicists included early
observations of the effects of breathing on CT models of
anatomy as well as delivered dose and necessary treatment
margins.87–90 In the process of determining various ways of
optimally managing breathing motions, innovations such as
active breathing control,91 gated radiotherapy,90,92 tracking
systems,93 and breathing-sorted 4D CT Ref. 94 and 95
followed in rapid succession.
IV. 2008: AAPM GOLDEN ANNIVERSARY
In 2008, dynamic imaging permits appreciation of motion
in the pancreas. Deformable image registration promises to
better describe the relationship between MRI and CT patient
models, as well as different states of the patient during
breathing. A breathing gated or breath held, intensity
modulated, treatment can be delivered, with potential in-
creases in pancreas tumor dose at acceptable toxicity as-
sessed to some extent by models of normal tissue toxicity
integrated within the treatment planning framework. Indi-
vidual metastases are potentially treated with very high pre-
cision stereotactic techniques. Intensity modulation may en-
hance the delivery of particle therapy, with the potential to
dramatically change the expected precision of planned dose
conformance.
V. THE CURRENT AND EMERGING ERA OF NOVEL
TECHNOLOGY IN RADIATION THERAPY
As we approach the present and future, we can look back
at an impressive legacy of skill and ingenuity on the part of
medical physicists in radiation oncology. Physicists have
been able to adapt their education and skills to address com-
FIG. 23. Prostate movement due to rectal filling state courtesy of R. Ten
Haken.plex needs in the medical field. The concepts applied to the
5650 S. Balter and J. M. Balter: Novel technologies in radiation oncology 5650innovative developments have varied widely, including de-
veloping and applying fundamental physical theories to pro-
duce new methods of delivering and detecting radiation, ap-
plying advanced mathematical and practical models to map
radiation deposition, model and measure variations in treat-
ment and patient configuration, and improve our understand-
ing of radiation effects on tumor and normal tissues, and
ways to optimize treatment planning and delivery based on
modeled responses.
We can already see some hints of the future. A major
current initiative is the further integration of soft tissue im-
aging especially MRI Ref. 96 and 97 into the treatment
unit. Advances in functional imaging of various forms98,99
are being applied to better understand patient-specific radia-
tion effects in attempts to better individualize treatment. Mo-
lecular targeted therapy is reemerging, with nanotechnology
offering significant potential for local enhancement of imag-
ing as well as treatment delivery.
We can only imagine the roles that physicists will play in
the future of radiation oncology. It is critical that we keep the
skill set and interests of physicists high, as the environment
and technology that will lead to the next generation of inno-
vations is not predetermined. We should simultaneously wel-
come and encourage collaboration with medical, biological,
and engineering sciences, as our past and current efforts
clearly point towards significant developments in enhancing
human health through multidisciplinary approaches in these
very complex and rapidly advancing areas.
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